Daniel Stauder
Stock Analyst at Citizens Capital Markets
(0)
# 3641
Out of 5,283 analysts
14
Total ratings
25.00%
Success rate
-0.48%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Neuronetics | Maintains: Market Outperform | 3 7 | 4.92 | 42.28% | 1 | Mar 5, 2025 | |
LeMaitre Vascular | Maintains: Strong Buy | 105 110 | 85.05 | 29.34% | 4 | Feb 28, 2025 | |
Axon Enterprise | Reiterates: Market Outperform | 725 725 | 540.5 | 34.14% | 1 | Feb 26, 2025 | |
Artivion | Reiterates: Market Outperform | 33 33 | 24.2 | 36.36% | 3 | Feb 25, 2025 | |
AtriCure | Reiterates: Market Outperform | 60 60 | 33.87 | 77.15% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | May 7, 2024 |